156 filings
Page 4 of 8
8-K
oxgrof hz74x9leozh
3 Oct 23
Regulation FD Disclosure
7:00am
RW WD
7x67axda3z2 9xdor
2 Oct 23
Withdrawal of registration withdrawal request
9:42pm
RW
1hqnovgi73bfaak
2 Oct 23
Registration withdrawal request
4:00pm
CORRESP
iotg 5mxz36dqjm5d
2 Oct 23
Correspondence with SEC
12:00am
UPLOAD
32qyenu azuvkw
2 Oct 23
Letter from SEC
12:00am
CORRESP
4z3 w0pe71
29 Sep 23
Correspondence with SEC
12:00am
8-K
3bk txlkz
28 Sep 23
Renalytix Reports Full Year Fiscal 2023 Results
7:31am
S-3
tzjkxq9h
28 Sep 23
Shelf registration
6:58am
POS AM
sauj8x5m p3
28 Sep 23
Prospectus update (post-effective amendment)
6:55am
POS AM
8vd7uqlkjw0m 4t96
28 Sep 23
Prospectus update (post-effective amendment)
6:54am
S-8
fky7xo0t
28 Sep 23
Registration of securities for employees
6:49am
10-K
nlm yp5reix
28 Sep 23
Annual report
6:18am
8-K
bz2 1qlubib71
22 Sep 23
Regulation FD Disclosure
7:00am
8-K
7ox2i4xg056p3acq
8 Sep 23
Renalytix Appoints Senior Executive Howard Doran as Chief Business Officer
4:04pm
8-K
tp0r753 erm2qwll
21 Aug 23
Regulation FD Disclosure
7:00am
8-K
p4k6rymrys46q5h 9jk
17 Jul 23
Regulation FD Disclosure
5:16pm
8-K
oo3f40nb
3 Jul 23
Renalytix Appoints Financial Executive Catherine Coste to its Board of Directors
2:30pm
8-K
o08 xr04a7m
3 Jul 23
Regulation FD Disclosure
8:00am
6-K
qa74q6vy5fzjtgqib
30 Jun 23
Current report (foreign)
7:00am
6-K
fepk2 0t7s4moz
9 Jun 23
Current report (foreign)
4:05pm